check_circleStudy Completed

Relative bioavailability of rivaroxaban under different administration conditions

Trial purpose

Key Participants Requirements

Sex

Male

Age

18 - 55 Years
  • -

  • -

Trial summary

Enrollment Goal
16
Trial Dates
March 2015 - June 2015
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Xarelto (Rivaroxaban, BAY59-7939)
Accepts Healthy Volunteer
Yes

Where to participate

StatusInstitutionLocation
Completed
Mannheim, 68167, Germany

Trial design

Single-dose, open-label, randomized, 5-way crossover study to compare different administration conditions of the oral suspension of rivaroxaban in healthy subjects
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
Randomized
Blinding
Open Label
Assignment
Crossover Assignment
Trial Arms
N/A